Loading
MMS Holdings Inc. is a globally recognized Clinical Research Organization (CRO) based in Canton, Michigan. With a focus on data-driven solutions, MMS supports pharmaceutical, biotechnology, and medical device companies throughout all stages of drug development. The company has a strong track record, having completed over 50 drug approval submissions in the last five years and operating across four continents with over 800 employees. MMS offers a comprehensive range of services, including regulatory and medical writing, biometrics and data science, drug safety and pharmacovigilance, quality and compliance, and technology-enabled services. Their expertise is enhanced by AI-driven technology, allowing them to manage complex trial data effectively. Recognized for their excellence, MMS has received multiple awards, including the title of Best Data-Focused Pharmaceutical Clinical Research Organisation in the USA at the GHP Global Excellence Awards 2023.